InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives - InspireMD (NASDAQ:NSPR)

Announces hiring of Patrick Verta, MD, as Executive VP of Clinical and Medical Affairs Cheryl Tal joins as VP of Quality Assurance and Regulatory Affairs Shane Gleason, current General Manager of North

Related Keywords

Israel ,Galil ,Ha Afon ,Miami ,Florida ,United States ,Forsan ,Languedoc Roussillon ,France ,Paris ,France General ,America ,Patrick Verta ,Chuck Padala ,Shane Gleason ,Edwards Lifesciences ,Marvin Slosman ,Phase Ltd ,Redent Nova Ltd ,Company Annual Report On Form ,Impliant Ltd ,Exchange Commission ,Global Medical Affairs ,Orsan Medical Technologies Ltd ,Inspiremd Inc ,Nasdaq ,Mckesson ,Regulatory Affairs ,Compensation Committee Of Inspiremd Board Directors ,A Lapidot Pharmaceuticals Ltd ,Quality Assurance ,General Manager ,North America ,Global Marketing ,Chief Commercial ,Embolic Prevention Stent System ,Executive Vice President ,Medical Affairs ,Cheryl Tal ,Vice President ,Chief Executive Officer ,Key Opinion Leader ,Chief Commercial Officer ,Canary Medical ,Chief Medical ,Clinical Science ,Transcatheter Mitral ,Tricuspid Therapies ,Sunshine Heart ,Abbott Vascular ,New Phase Ltd ,Change Healthcare ,Galil Medical ,Compensation Committee ,Compensation Plan ,Nasdaq Listing Rule ,Annual Report ,Quarterly Reports ,